Examining the Protective Role of ErbB2 Modulation in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype

(2013) Christine Y. Ivashchenko et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Structural and Functional Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells

(2013) Scott D. Lundy et al.   STEM CELLS AND DEVELOPMENT

Phenotypic Profiling of Structural Cardiotoxins In Vitro Reveals Dependency on Multiple Mechanisms of Toxicity

(2013) Amy Pointon et al.   TOXICOLOGICAL SCIENCES

The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferation

(2012) Brian Wadugu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Differentiation of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells to Cardiomyocytes

(2012) Christine L. Mummery et al.   CIRCULATION RESEARCH

High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents

(2011) Junyi Ma et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?

(2011) HG Laverty et al.   BRITISH JOURNAL OF PHARMACOLOGY

Opportunities for Use of Human iPS Cells in Predictive Toxicology

(2011) B D Anson et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes

(2011) Thomas Force et al.   NATURE REVIEWS DRUG DISCOVERY

Estimating the Risk of Drug-Induced Proarrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes

(2011) Liang Guo et al.   TOXICOLOGICAL SCIENCES

The Vulnerability of the Heart As a Pluricellular Paracrine Organ

(2010) Gilles W. De Keulenaer et al.   CIRCULATION RESEARCH

Cytostatic Drugs, Neuregulin Activation of ErbB Receptors, and Angiogenesis

(2010) Nadia Hedhli et al.   CURRENT HYPERTENSION REPORTS

Modulation of human embryonic stem cell-derived cardiomyocyte growth: A testbed for studying human cardiac hypertrophy?

(2010) Gábor Földes et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Dedifferentiation and Proliferation of Mammalian Cardiomyocytes

(2010) Yiqiang Zhang et al.   PLoS One

Altered cytosolic Ca2+ dynamics in cultured Guinea pig cardiomyocytes as an in vitro model to identify potential cardiotoxicants

(2010) Jian-Yong Qian et al.   TOXICOLOGY IN VITRO

Stem Cells and Their Derivatives: A Renaissance in Cardiovascular Translational Research

(2010) Steven J. Kattman et al.   Journal of Cardiovascular Translational Research

Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins

(2009) Yun Bian et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Trastuzumab versus lapatinib: The cardiac side of the story

(2009) Hamdy Azim et al.   CANCER TREATMENT REVIEWS

Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens

(2009) Alice C Fan et al.   NATURE MEDICINE

Cardioprotective Signaling by Endothelin

(2009) Anita Schorlemmer et al.   TRENDS IN CARDIOVASCULAR MEDICINE

ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium

(2008) Stephen J. Fuller et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY